Guangzhou Surveillance and Clinical Study in Microcephaly (GSCSM)
2 other identifiers
observational
47,369
1 country
1
Brief Summary
Screening for microcephaly is important at birth and during early childhood. The Guangzhou Surveillance and Clinical Study in Microcephaly (GSCSM) aims to establish a multicentric surveillance system for microcephaly in newborns and infants, to develop a new head circumference reference and microcephaly criteria basing on the local population in Guangzhou, to improve the prediction model of microcephaly, and to follow up the outcomes of the children diagnosed with microcephaly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2017
CompletedFirst Submitted
Initial submission to the registry
August 22, 2018
CompletedFirst Posted
Study publicly available on registry
August 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2024
CompletedOctober 1, 2024
September 1, 2024
7.6 years
August 22, 2018
September 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of microcephaly
Assessed by the head circumference measured using a standard tool
At birth
Secondary Outcomes (2)
Neurodevelopmental performance of children
At birth, 6 weeks, 6 months, 1 year and 2 years
Head circumference changes of children
At birth, 6 weeks, 6 months, 1 year to 2 years
Eligibility Criteria
The study population are infants born in the maternity hospitals from Guangzhou surveillance system.
You may qualify if:
- Newborns born after 24+0 weeks of gestation
- Newborns delivered at the study hospitals
You may not qualify if:
- With major congenital abnormalities
- Multiple births
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangzhou Women and Children's Medical Center, China
Guangzhou, China
Related Publications (1)
He JR, Li WD, Lu MS, Guo Y, Chan FF, Lu JH, Zhang LF, Shen SY, Xia XY, Wang P, Mo WJ, Lam KBH, Hirst JE, Xia HM, Qiu X. Birth weight changes in a major city under rapid socioeconomic transition in China. Sci Rep. 2017 Apr 21;7(1):1031. doi: 10.1038/s41598-017-01068-w.
PMID: 28432291BACKGROUND
Biospecimen
At birth: cord, cord blood and placenta; During infancy: oral swab.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiu Qiu, MD,PhD
Guangzhou Women and Children's Medical Center, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Born in Guangzhou Cohort Study
Study Record Dates
First Submitted
August 22, 2018
First Posted
August 29, 2018
Study Start
February 10, 2017
Primary Completion
September 27, 2024
Study Completion
September 27, 2024
Last Updated
October 1, 2024
Record last verified: 2024-09